Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma and Narrow Angle Glaucoma

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 23, 2022

Primary Completion Date

February 19, 2025

Study Completion Date

December 15, 2025

Conditions

Glaucoma, Open-AngleGlaucoma, Narrow Angle

Interventions

DEVICE

Interposition supraciliary implant

Surgical placement of SV22 interposition supraciliary implant in the supraciliary space

Trial Locations (1)

Malayan center, Yerevan